Experimental infection and protection against ... - TI Pharma

A saturation of antibody avidity and concentration induced by malaria vaccine
candidate Apical Membrane Antigen 1
References
1. Ferreira MU, Katzin AM. The assessment of antibody affinity distribution by
thiocyanate elution: a simple dose-response approach. J Immunol Methods
1995; 187:297-305.
2. Kaattari SL, Zhang HL, Khor IW, Kaattari IM, Shapiro DA. Affinity maturation in
trout: clonal dominance of high affinity antibodies late in the immune response.
Dev Comp Immunol 2002; 26:191-200.
3. Mitchell GH, Thomas AW, Margos G, Dluzewski AR, Bannister LH. Apical
membrane antigen 1, a major malaria vaccine candidate, mediates the close
attachment of invasive merozoites to host red blood cells. Infect Immun 2004;
72:154-8.
4. Dutta S, Haynes JD, Barbosa A, et al. Mode of Action of Invasion-Inhibitory
Antibodies Directed against Apical Membrane Antigen 1 of Plasmodium
falciparum. Infect Immun 2005; 73:2116-22.
5. Thomas AW, Deans JA, Mitchell GH, Alderson T, Cohen S. The Fab fragments of
monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi
invasion of erythrocytes. Mol Biochem Parasitol 1984; 13:187-99.
6. Treeck M, Tamborrini M, Daubenberger CA, Gilberger TW, Voss TS. Caught in
action: mechanistic insights into antibody-mediated inhibition of Plasmodium
merozoite invasion. Trends Parasitol 2009; 25:494-7.
7. Remarque EJ, Faber BW, Kocken CH, Thomas AW. Apical membrane antigen 1: a
malaria vaccine candidate in review. Trends Parasitol 2008; 24:74-84.
8. Faber BW, Remarque EJ, Kocken CH, et al. Production, quality control, stability
and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO
strain ectodomain expressed in Pichia pastoris. Vaccine 2008; 26:6143-50.
9. Roestenberg M, Remarque E, de JE, et al. Safety and immunogenicity of a
recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with
Alhydrogel, Montanide ISA 720 or AS02. PLoS One 2008; 3:e3960.
10. Polley SD, Mwangi T, Kocken CH, et al. Human antibodies to recombinant
protein constructs of Plasmodium falciparum Apical Membrane Antigen 1
(AMA1) and their associations with protection from malaria. Vaccine 2004;
23:718-28.
11. Kocken CH, Withers-Martinez C, Dubbeld MA, et al. High-level expression of the
malaria blood-stage vaccine candidate Plasmodium falciparum apical
membrane antigen 1 and induction of antibodies that inhibit erythrocyte
invasion. Infect Immun 2002; 70:4471-6.
12. Kocken CH, van der Wel AM, Dubbeld MA, et al. Precise timing of expression of
a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical
93